Renaissance Technologies
BEAT

Renaissance Technologies’s BioTelemetry, Inc. BEAT Stock Holding History

Renaissance Technologies’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-263,420
Closed -$15.7M – 3870
2018
Q4 		$15.7M Buy
+263,420
New +$15.8M 0.02% 1033
2018
Q1 		– Sell
-560,500
Closed -$16.8M – 3765
2017
Q4 		$16.8M Sell
560,500
-392,900
-41% -$11.4M 0.02% 1071
2017
Q3 		$31.5M Sell
953,400
-132,200
-12% -$4.58M 0.04% 637
2017
Q2 		$36.3M Sell
1,085,600
-161,445
-13% -$4.82M 0.05% 512
2017
Q1 		$36.1M Buy
1,247,045
+147,745
+13% +$3.66M 0.05% 481
2016
Q4 		$24.6M Buy
1,099,300
+72,100
+7% +$1.41M 0.04% 655
2016
Q3 		$19.1M Buy
1,027,200
+103,568
+11% +$1.95M 0.03% 734
2016
Q2 		$15.1M Buy
923,632
+49,732
+6% +$732K 0.03% 878
2016
Q1 		$10.2M Buy
873,900
+54,300
+7% +$607K 0.02% 1128
2015
Q4 		$9.57M Sell
819,600
-187,842
-19% -$2.38M 0.02% 1019
2015
Q3 		$12.3M Buy
1,007,442
+299,342
+42% +$3.82M 0.03% 801
2015
Q2 		$6.68M Buy
708,100
+77,800
+12% +$720K 0.02% 1237
2015
Q1 		$5.58M Sell
630,300
-22,200
-3% -$224K 0.01% 1291
2014
Q4 		$6.54M Sell
652,500
-84,800
-12% -$727K 0.02% 1118
2014
Q3 		$4.95M Sell
737,300
-39,900
-5% -$280K 0.01% 1168
2014
Q2 		$5.57M Buy
777,200
+61,400
+9% +$489K 0.01% 1159
2014
Q1 		$7.22M Buy
715,800
+51,800
+8% +$477K 0.02% 1052
2013
Q4 		$5.27M Sell
664,000
-211,300
-24% -$1.97M 0.01% 1167
2013
Q3 		$8.67M Buy
875,300
+371,300
+74% +$2.92M 0.02% 875
2013
Q2 		$2.97M Buy
+504,000
New +$1.7M 0.01% 1371

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies's BEAT Position: Q1 2019 in Review

Renaissance Technologies sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 263,420 shares — an estimated $15.7M sold.

Renaissance Technologies first reported a position in BEAT in Q2 2013 and held it in 20 quarters. The position peaked at $36.3M in Q2 2017. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • Renaissance Technologies reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • Renaissance Technologies sold 263,420 BioTelemetry, Inc. shares in Q1 2019, an estimated $15.7M.
  • Renaissance Technologies first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 20 quarters.
  • Renaissance Technologies's BioTelemetry, Inc. position peaked at $36.3M in Q2 2017.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.